# Prognostic Model for MASLD Related Cirrhosis

> **NCT07082751** · — · NOT_YET_RECRUITING · sponsor: **Beijing Friendship Hospital** · enrollment: 228 (estimated)

## Conditions studied

- Metabolic Dysfunction Associated Steatotic Liver Disease
- Compensated Cirrhosis

## Interventions

- **BEHAVIORAL:** Lifestyle Guidance

## Key facts

- **NCT ID:** NCT07082751
- **Lead sponsor:** Beijing Friendship Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08-13
- **Primary completion:** 2030-06-30
- **Final completion:** 2030-06-30
- **Target enrollment:** 228 (ESTIMATED)
- **Last updated:** 2025-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07082751

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07082751, "Prognostic Model for MASLD Related Cirrhosis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07082751. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*